Valuation Conexeu Sciences Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-23 EDT			5-day change	1st Jan Change
3.100 ^USD	-6.06%		+1.31%	-

10-15	Conexeu Sciences Closes $5 Million Private Placement	MT
10-14	Conexeu Sciences Inc. announced that it has received $5 million in funding	CI

Data adjusted to current consolidation scope

Fiscal Period: October	2026	2027	2028
Market Cap ¹	87.44	-	-
Change	-	-	-
Enterprise Value (EV)	87.44	87.44	87.44
Change	-	0%	0%
P/E	-7.75x	-5.85x	3.04x
PBR	-	-	-
PEG	-0.3x	-0.2x	-0x
Capitalization / Revenue	-	-	0.62x
EV / Revenue	-	-	0.62x
EV / EBITDA	-	-	-
EV / EBIT	-9.12x	-5.92x	2.16x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-0.4	-0.53	1.02
Distribution rate	-	-	-
Net sales ¹	-	-	140.2
EBITDA	-	-	-
EBIT ¹	-9.592	-14.78	40.51
Net income ¹	-9.512	-14.78	37.92
Net Debt	-	-	-
Reference price ²	3.100	3.100	3.100
Nbr of stocks (in thousands)	28,207	-	-
Announcement Date	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CONEXEU SCIENCES INC.	-7.75x	-	-	-	87.44M
WUXI APPTEC CO., LTD.	18.83x	6.63x	13.18x	1.58%	64.69B
ARGENX SE	30.16x	8x	26.2x	0.05%	54.78B
LONZA GROUP AG	36.79x	6.53x	19.51x	0.88%	53.49B
IQVIA HOLDINGS INC.	35.59x	3.45x	14.87x	-.--%	45.98B
BEONE MEDICINES AG	49.71x	5.74x	31.52x	-.--%	42.94B
REVOLUTION MEDICINES, INC.	-19.41x	187.75x	-20.66x	-.--%	40.08B
CELLTRION, INC.	28.93x	8.21x	21.27x	0.37%	33.52B
WUXI BIOLOGICS (CAYMAN) INC.	27.67x	5.83x	15.12x	-.--%	23.97B
GENMAB A/S	32.66x	5.97x	20.09x	-.--%	23.67B
Average	23.32x	26.46x	15.68x	0.32%	38.32B
Weighted average by Cap.	26.71x	25.33x	15.90x	0.43%